Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.

Similar documents
Rpts. GENERAL General Schedule (Code GE)

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives

High use of maintenance therapy after triple therapy regimes in Ireland

Proton Pump Inhibitors (PPIs) (Sherwood Employer Group)

Proton Pump Inhibitors

Proton Pump Inhibitors. Description

Measuring and Evaluating Indicators of Appropriate Prescribing in Older. Populations

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

European Medicines Agency decision

Proton Pump Inhibitor De-prescribing Guidance

Public Assessment Report. Scientific discussion. Rabeprazolnatrium Torrent Pharma. 10 mg and 20 mg gastro-resistant tablets. Rabeprazole sodium

Drug Class Monograph

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW

Setting The setting was primary care. The economic analysis was conducted in Glasgow, UK.

Proton Pump Inhibitors Drug Class Prior Authorization Protocol

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

Patient advice regarding long term use of Proton Pump Inhibitors (PPIs)

Committee Approval Date: October 14, 2014 Next Review Date: October 2015

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF LOSEC AND ASSOCIATED NAMES (SEE ANNEX I)

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

See Important Reminder at the end of this policy for important regulatory and legal information.

EU RISK MANAGEMENT PLAN (EU RMP)

Difference between omeprazole and omeprazole delayed release

Developing Evidence-Based Best Practices for the Prescribing and Use of Proton Pump Inhibitors in Canada

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Study population The study population comprised hypothetical patients with gastric and duodenal ulcer.

This PDF is available for free download from a site hosted by Medknow Publications

Policy Evaluation: Proton Pump Inhibitors (PPIs)

Review article: gastric acidity ) comparison of esomeprazole with other proton pump inhibitors

A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.

Peptic ulcer disease Disorders of the esophagus

Package leaflet: Information for the user. PARIET 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

Pharmacoeconomic analysis of proton pump inhibitor therapy and interventions to control Helicobacter pylori infection Klok, Rogier Martijn

PATIENT INFORMATION LEAFLET PEPLOC RANGE

Source of effectiveness data The effectiveness data were derived from a review and synthesis of completed studies.

Nexium 24HR. Tools and information for you and your pharmacy team NOW OTC FOR FREQUENT HEARTBURN. Consumer Healthcare Pfizer Inc.

Drug Class Review on Proton Pump Inhibitors

Management of dyspepsia and of Helicobacter pylori infection

Appropriate Use of Proton Pump Inhibitors (PPIs) Anderson Mabour, Pharm.D., BCPS Clinical Pharmacy Specialist

Package leaflet: Information for the patient. Rabeprazole 20 mg Gastro-resistant Tablets. (rabeprazole sodium)

Some H2 Antihistaminics And Ppi-S Products Authorized In Albania And Their Availability For Pediatric Groups

Drug Class Review on Proton Pump Inhibitors

NOXICID CAPS Esomeprazole (as magnesium) PRODUCT INFORMATION

Prevpac Pylera Omeclamox-Pak

AstraZeneca and Daiichi Sankyo Launch Proton Pump Inhibitor Nexium 10 mg and 20 mg Granules for Suspension, Sachet, in Japan

PPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI)

Concise guide to management of reflux disease in primary care

Setting The setting was secondary care. The economic study was carried out in Hong Kong, China.

Clinical guideline Published: 3 September 2014 nice.org.uk/guidance/cg184

All Indiana Medicaid Prescribers and Pharmacy Providers

H o w d o e a c t. y o u r a c i

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated

Management of Dyspepsia

Internal Clinical Guidelines Team

ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER

Drug Class Review Proton Pump Inhibitors

Setting The setting was community. The economic study was carried out in the USA.

PACKAGE INSERT. 10mg: Each enteric-coated delayed release tablet contains 10 mg of rabeprazole sodium, equivalent

Zantac for stomach ulcers

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011

Gastric ulcer: The recommended dosage is Pepzol 20 mg once daily. Symptom resolution is rapid and in most

Controloc 40 mg is used for:

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release capsule (Manufacturer s standard)

1.1 Product name: RABESTA-10 (Rabeprazole sodium Tablets 10 mg) 1.2 Strength: Each enteric coated tablet contains: Rabeprazole sodium...

Package leaflet: Information for the user. Ulcerbrex 20 mg gastro-resistant tablets Rabeprazole sodium

LOSEC MUPS 10 mg, 20 mg and 40 mg Tablets ASTRAZENECA

Patient Satisfaction with Proton-pump Inhibitors in a Tertiary Care Teaching Hospital

Class Update: Proton Pump Inhibitors and Histamine 2 Receptor Antagonists

PACKAGE LEAFLET: INFORMATION FOR THE USER. ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

Applicant Invented name Strength Pharmaceutical Form Route of administration HEXAL AG Industriestraße 25 D Holzkirchen.

International Journal of Research in Pharmacology & Pharmacotherapeutics

Management of dyspepsia in adults in primary care

Rabeprazole Clonmel 10mg Gastro-resistant Tablets Rabeprazole Clonmel 20mg Gastro-resistant Tablets

NAME OF THE MEDICINAL PRODUCT

Package leaflet: Information for the user. Omeprazol STADA 20 mg gastro-resistant tablets Omeprazole

II. Angiotensin Receptor Blockers (ARBs) Drug Class Review

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

Texas Prior Authorization Program Clinical Criteria. This criteria was recommended for review by an MCO to ensure appropriate and safe utilization.

Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily a randomized, two-way crossover study

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R

Copy right protected Page 1

Package leaflet: Information for the user. Nolpaza 40 mg gastro-resistant tablets. Pantoprazole

ALL WALES PROTON PUMP INHIBITOR AND DYSPEPSIA RESOURCE PACK MATERIAL TO SUPPORT APPROPRIATE PRESCRIBING OF PROTON PUMP INHIBITORS ACROSS WALES

Drug Class Literature Scan: Proton Pump Inhibitors and Histamine-2 Receptor Antagonists

New Therapeutic Options in the Treatment of GERD and Other Acid-Peptic Disorders

Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease where next?

Package leaflet: Information for the patient

Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori Taylor J L, Zagari M, Murphy K, Freston J W

How Rabeprazole Sandoz works

1. The proposed strength, quantity, dosage form, dose and route of administration of the medicine including indication

You May Be at Risk. You are currently taking a proton-pump inhibitor (PPI): Dexlansoprazole (Dexilant ) Pantoprazole (Pantoloc, Panto IV )

Clinical Trial of Efcid (Himcocid) in Patients of Acid Peptic Disease

* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte.

Transcription:

Omeprazole 10mg Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Gastro-oesophageal reflux disease

Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Scleroderma oesophagus

Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Zollinger-Ellison syndrome

Omeprazole 20mg Name, Restriction, Manner of administration and form omeprazole 20 mg Tablet, 30 (8331L, 9109K) omeprazole 20 mg capsule, 30 (1326T) 1 1 1 1 Peptic Ulcer Treatment phase: Clinical criteria: Initial treatment The therapy must be for initial treatment of a peptic ulcer, in a patient testing negative for helicobacter pylori infection OR The patient must have failed treatment with helicobacter pylori eradication therapy

Helicobacter pylori eradication therapy should be considered. Pharmaceutical benefits that have the forms omeprazole tablet 20 mg, omeprazole capsule 20 mg and omeprazole tablet 20 mg (as magnesium) are equivalent for the purposes of substitution. Low dose proton pump inhibitors are appropriate step-down therapy from standard dose proton pump inhibitors A low dose proton pump inhibitor includes: lansoprazole 15mg, omeprazole 10mg, pantoprazole 20mg and rabeprazole 10mg No increase in the maximum number of repeats may be No increase in the maximum quantity or number of repeats may be

Name, Restriction, Manner of administration and form omeprazole 20 mg Tablet, 30 (8333N, 9110L) omeprazole 20 mg capsule, 30 (1372W) Max. Scleroderma oesophagus Treatment criteria: Must be treated by a gastroenterologist or in consultation with a gastroenterologist Pharmaceutical benefits that have the forms omeprazole tablet 20 mg, omeprazole capsule 20 mg and omeprazole tablet 20 mg (as magnesium) are equivalent for the purposes of substitution. Low dose proton pump inhibitors are appropriate step-down therapy from standard dose proton pump inhibitors A low dose proton pump inhibitor includes: lansoprazole 15mg, omeprazole 10mg, pantoprazole 20mg and rabeprazole 10mg No increase in the maximum quantity or number of repeats may be

Name, Restriction, Manner of administration and form omeprazole 20 mg Tablet, 30 (8333N, 9110L) omeprazole 20 mg capsule, 30 (1372W) Zollinger-Ellison syndrome Treatment criteria: Must be treated by a gastroenterologist or in consultation with a gastroenterologist Pharmaceutical benefits that have the forms omeprazole tablet 20 mg, omeprazole capsule 20 mg and omeprazole tablet 20 mg (as magnesium) are equivalent for the purposes of substitution. Low dose proton pump inhibitors are appropriate step-down therapy from standard dose proton pump inhibitors A low dose proton pump inhibitor includes: lansoprazole 15mg, omeprazole 10mg, pantoprazole 20mg and rabeprazole 10mg No increase in the maximum quantity or number of repeatsmay be

Name, Restriction, Manner of administration and form omeprazole 20 mg Tablet, 30 (8333N, 9110L) omeprazole 20 mg capsule, 30 (1372W) Max. Gastro-oesophageal reflux disease Clinical criteria: The treatment must be maintenance therapy for erosive reflux oesophagitis AND The condition must have been previously diagnosed by endoscopy Pharmaceutical benefits that have the forms omeprazole tablet 20 mg, omeprazole capsule 20 mg and omeprazole tablet 20 mg (as magnesium) are equivalent for the purposes of substitution Low dose proton pump inhibitors are appropriate step-down therapy from standard dose proton pump inhibitors A low dose proton pump inhibitor includes: lansoprazole 15mg, omeprazole 10mg, pantoprazole 20mg and rabeprazole 10mg No increase in the maximum quantity or number of repeats may be

Name, Restriction, Manner of administration and form omeprazole 20 mg Tablet, 30 (New) 1 1 omeprazole 20 mg capsule, 30 (New) 1 1 Gastro-oesophageal reflux disease Clinical criteria: The treatment must be for initial treatment of symptomatic gastrooesophageal reflux disease OR The treatment must be for the short-term maintenance treatment of gastrooesophageal reflux disease Pharmaceutical benefits that have the forms omeprazole tablet 20 mg, omeprazole capsule 20 mg and omeprazole tablet 20 mg (as magnesium) are equivalent for the purposes of substitution. Low dose proton pump inhibitors are appropriate step-down therapy from standrad dose proton pump inhibitors A low dose proton pump inhibitor includes: lansoprazole 15mg, omeprazole 10mg, pantoprazole 20mg and rabeprazole 10mg No increase in the maximum quantity or number of repeats may be